Streetbeat News

Price Targets

PFS

Keefe, Bruyette & Woods has upgraded Provident Financial Services (NYSE:PFS) from Market Perform to Outperform and raised the price target from $20 to $21.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:20 am

DOLE

Goldman Sachs analyst Adam Samuelson maintains a Buy rating on Dole (NYSE:DOLE) and raises the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:16 am

VVV

Baird analyst Justin Kleber has initiated coverage on Valvoline (NYSE:VVV) with an Outperform rating and set a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:12 am

IRS

Jefferies analyst Pedro Baptista has upgraded IRSA Inversiones y (NYSE:IRS) from Hold to Buy and raised the price target from $10.5 to $13.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:11 pm

FNKO

DA Davidson analyst Linda Bolton Weiser maintains a Buy rating on Funko (NASDAQ:FNKO) with a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 9:35 pm

DHX

Barrington Research analyst Gary Prestopino maintains an Outperform rating on DHI Group (NYSE:DHX) with a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 9:27 pm

ADBE

Financial giants have shown a bullish sentiment towards Adobe (NASDAQ:ADBE) with significant options trading activity. Analysis reveals 32 unusual trades, with 46% bullish and 25% bearish. The projected price target for Adobe ranges from $420 to $600. The stock is currently trading at $539.79, up by 0.85%. An analyst from RBC Capital has lowered its rating to Outperform with a new price target of $600.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 8:30 pm

ETN

Financial giants have shown a bullish trend in options trading for Eaton Corp (NYSE:ETN), with 50% of traders being bullish. The options trades include 4 puts valued at $135,620 and 4 calls valued at $262,355. Analysts have set a consensus target price of $335.0 for Eaton Corp, with ratings ranging from Equal-Weight to Outperform.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 8:00 pm

GANX

Gain Therapeutics shares are trading higher after Oppenheimer issued an Outperform rating on the stock and announced a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 7:26 pm

NPCE

Neuropace shares are trading lower following the company's Q2 financial results and a price target downgrade from Wells Fargo from $20 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 7:24 pm